mRNA |
JNJ-26854165 |
CTRPv2 |
pan-cancer |
AAC |
-0.047 |
0.2 |
mRNA |
tamatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.051 |
0.2 |
mRNA |
NVP-231 |
CTRPv2 |
pan-cancer |
AAC |
0.044 |
0.2 |
mRNA |
IC-87114 |
CTRPv2 |
pan-cancer |
AAC |
0.05 |
0.2 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.045 |
0.2 |
mRNA |
thalidomide |
CTRPv2 |
pan-cancer |
AAC |
0.071 |
0.2 |
mRNA |
Vorinostat |
gCSI |
pan-cancer |
AAC |
-0.068 |
0.2 |
mRNA |
lapatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.048 |
0.2 |
mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.048 |
0.2 |
mRNA |
manumycin A |
CTRPv2 |
pan-cancer |
AAC |
0.042 |
0.2 |